Tempest Therapeutics, Inc. - Bathi operasional EBITDA TPST
The success of Tempest Therapeutics (TPST) depends on clinical trial outcomes and the rate of cash burn. EBITDA_Co dynamics demonstrate the ability to act as a cash generator under market pressure, where 0.00 is the current level of the indicator. Tempest Therapeutics (TPST) develops small molecules to combat tumors, focusing on PPAR inhibitors. Simultaneously, the business is mitigating risks by creating metabolic drugs for the therapy of colorectal and liver cancers.
Tempest Therapeutics, Inc. (TPST) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang Agregat marang Modal Tempest Therapeutics|TPST - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Tempest Therapeutics Inc|TPST - Utang perusahaan|Utang marang nilai buku Tempest Therapeutics|TPST - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Tempest Therapeutics|Likuiditas darurat tempesttx.com
- statistik bathi lan rasio pasar:
TPST - Bathi resik perusahaan|Prakiraan bathi perusahaan Tempest Therapeutics|TPST - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep tempesttx.com|TPST - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Tempest Therapeutics|TPST - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Tempest Therapeutics|TPST - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan tempesttx.com|TPST - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Tempest Therapeutics
Analisis kabeh metrik perusahaan:TPST - Tempest Therapeutics Corp
This indicator measures cash flow from core operations before taxes and debt obligations, allowing for an assessment of the business's actual ability to generate resources in an environment of expensive capital. By analyzing the total operating profit of Tempest Therapeutics (TPST), an investor can gauge the financial stability of Tempest Therapeutics (TPST) while developing innovative oncology drugs and scaling methods for activating the immune response against liver tumors.
Pesaing Tempest Therapeutics (TPST)
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional sadurunge ngurangi amortisasi PSNL (Personalis, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ERAS|Bathi operasional EBITDA DCTH (Delcath Systems)|Y-mAbs Therapeutics Inc (YMAB) - Bathi sadurunge bunga, pajak, lan amortisasi|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Candel Therapeutics (CADL) - Bathi operasional sadurunge ngurangi amortisasi|Accuray Incorporated (ARAY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi SLS (SELLAS Life Sciences Group)|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Citius Oncology Inc. CTOR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TuHURA Biosciences, Inc. (HURA)|Pendapatan operasional sadurunge ngurangi amortisasi Protara Tx|Fate Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi WHWK (Aadi Bioscience, Inc.)|TCRX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CSBR (Champions Oncology)|XBIT (xbiotech.com) - Bathi operasional sadurunge ngurangi amortisasi|CVM: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|OSTX (OS Therapies Incorporated) - Bathi operasional EBITDA|RADX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ARTV|ANL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Veru Pharma VERU|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi XLO|Enochian BioSciences - Bathi operasional EBITDA|MURA - Bathi operasional EBITDA|kairospharma.com (KAPA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi OKUR (OnKure Therapeutics)|GDTC (CytoMed Therapeutics Ltd) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Curis Corp CRIS|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|Bathi operasional EBITDA tharimmune.com (THAR)|Advanced Biomed - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi GNPX (Genprex Inc.)|Calidi Bio - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi sunshinebiopharma.com SBFM|XBIO: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi salariuspharma.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Purple Biotech Ltd.|AON (AONC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi BGNE (BeOne Medicines)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi CKPT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|ICAD (iCAD Inc.) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|IKNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Notable Labs Ltd NTBL|VIRX (viracta.com) - Bathi operasional sadurunge ngurangi amortisasi|MOR: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ascentage.com (AAPGV)
